October 17, 2025

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring a Potential 166.54% Upside

Investors seeking opportunities in the biotech sector may find Kura Oncology, Inc. (NASDAQ: KURA) an intriguing prospect. Headquartered in San Diego, California, this clinical-stage biopharmaceutical company..

Eton Pharmaceuticals, Inc. (ETON): Exploring a 63.58% Upside Potential and Analyst Ratings

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) stands out in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing. Based in the United States,..

AxoGen, Inc. (AXGN) Stock Analysis: Exploring a 47.85% Upside Potential

AxoGen, Inc. (AXGN), a prominent player in the healthcare sector specializing in medical devices, is capturing investor attention with its impressive potential upside of 47.85%. As..

Cronos Group Inc. (CRON) Stock Analysis: Is the Current Price a Buying Opportunity Despite a -17% Potential Downside?

Investors eyeing the cannabis industry often find themselves considering Cronos Group Inc. (NASDAQ: CRON), a key player in the cannabinoid space with a growing international footprint...

InMode Ltd. (INMD) Stock Analysis: A Closer Look at Its Growth Potential and Market Position

InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector, specifically within the medical devices industry, has been making waves with its innovative aesthetic medical..

Evolus, Inc. (EOLS) Stock Analysis: Unraveling a Potential 198% Upside in the Aesthetic Healthcare Market

Evolus, Inc. (NASDAQ: EOLS), a dynamic player in the healthcare sector, specifically within the drug manufacturers’ specialty and generic segment, is making waves in the aesthetic..

Arbutus Biopharma (ABUS) Investor Outlook: Exploring a Potential 14.63% Upside

Arbutus Biopharma Corporation (NASDAQ: ABUS) is making waves in the biotechnology sector with its promising pipeline focused on addressing infectious diseases, particularly chronic Hepatitis B virus..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Potential 234% Upside with Promising Clinical Pipeline

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company, stands at the forefront of developing transformative cell and exosome-based therapeutics. With a focus on addressing unmet..

Valneva SE (VALN) Stock Analysis: Navigating a 31% Potential Upside in the Biotechnology Sector

Valneva SE (NASDAQ: VALN), a French biotechnology company, is gaining attention for its promising pipeline of vaccines targeting infectious diseases with unmet medical needs. With a..

Embecta Corp. (EMBC) Investor Outlook: Uncovering a 21.74% Potential Upside

Embecta Corp. (EMBC), a stalwart in the healthcare sector, is carving out its niche within the medical instruments and supplies industry. Headquartered in Parsippany, New Jersey,..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Exploring a Promising 115% Upside Potential in Biotech

Tyra Biosciences, Inc. (NASDAQ: TYRA) is capturing investor attention with its significant potential upside of 115.63%, as indicated by recent analyst ratings. This clinical-stage biotechnology company..

Pharvaris N.V. (PHVS) Stock Analysis: A Potential 70% Upside in the Biotech Arena

Pharvaris N.V. (PHVS), a biopharmaceutical company headquartered in Zug, Switzerland, is making waves in the healthcare sector with its innovative approach to tackling rare diseases. Specializing..

Auna SA (AUNA) Stock Analysis: Potential Upside of 89.10% Signals Strong Investment Opportunity

Auna SA (AUNA), a Luxembourg-based healthcare provider with operations extending across Mexico, Peru, and Colombia, is capturing the attention of investors with its promising potential upside..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: 87% Potential Upside Ignites Investor Interest

Taysha Gene Therapies, Inc. (TSHA) is making waves in the biotechnology sector with its impressive potential upside of 87.01%. With an average target price of $9.50,..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Biotech Innovator with 31% Upside Potential

LENZ Therapeutics, Inc. (NASDAQ: LENZ), a promising player in the biotechnology sector, is drawing significant investor interest with its focus on vision-improving therapies. As a biopharmaceutical..

Weave Communications, Inc. (WEAV) Stock Analysis: Navigating a Potential 85% Upside in the Healthcare Sector

Investors in the healthcare sector may want to keep an eye on Weave Communications, Inc. (NASDAQ: WEAV), a company that has carved out a niche in..

Immatics N.V. (IMTX) Stock Analysis: Potential 37% Upside in a Promising Biotech Sector

Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company based in Tübingen, Germany, is catching the attention of investors with its promising focus on T cell redirecting..

Delcath Systems, Inc. (DCTH) Investor Outlook: Assessing a 96.87% Potential Upside in the Healthcare Sector

Delcath Systems, Inc. (NASDAQ: DCTH), a prominent player in the healthcare sector specializing in medical devices, is captivating investor attention with its significant potential upside of..

Ferro-Alloy Resources Unveils Compelling Potential Following Robust Feasibility Study (LON:FAR) – Panmure Liberum

Ferro-Alloy Resources advances Balasausqandiq Project with low-cost vanadium and carbon production, supported by strong feasibility results...

Collegium Pharmaceutical, Inc. (COLL) Investor Outlook: Exploring a 34.3% Potential Upside

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) stands out in the healthcare sector, particularly in the realm of specialty pharmaceuticals focused on pain management. With a market capitalization..

Search

Funds

October 17, 2025

Ferro-Alloy Resources Unveils Compelling Potential Following Robust Feasibility Study (LON:FAR) – Panmure Liberum

Ferro-Alloy Resources advances Balasausqandiq Project with low-cost vanadium and carbon production, supported by strong feasibility results...
Search

Funds

October 17, 2025

FTSE 100

Funds